Joost J. Breeksema

Working with Weirdness: A Response to “Moving Past Mysticism in Psychedelic Science”

Joost J. Breeksema, Michiel van Elk · ACS Pharmacology & Translational Science · 2021 · 69 citations · Full text

Humanities, Psychiatry, Psychology +9

Patient perspectives and experiences with psilocybin treatment for treatment-resistant depression: a qualitative study

Joost J. Breeksema, Alistair Niemeijer, Erwin Krediet et al. · Scientific Reports · 2024 · 47 citations · Full text

Medicine, Pharmacotherapy, Psychiatry +15

Holding on or letting go? Patient experiences of control, context, and care in oral esketamine treatment for treatment-resistant depression: A qualitative study

Joost J. Breeksema, Alistair Niemeijer, Bouwe Kuin et al. · Frontiers in Psychiatry · 2022 · 40 citations · Full text

Pharmacy, Psychiatry, Psychology +17

Phenomenology and therapeutic potential of patient experiences during oral esketamine treatment for treatment-resistant depression: an interpretative phenomenological study

Joost J. Breeksema, Alistair Niemeijer, Bouwe Kuin et al. · Psychopharmacology · 2023 · 25 citations · Full text

Pharmacy, Pharmacology, Psychiatry +17

An international Delphi consensus for reporting of setting in psychedelic clinical trials

Chloé Pronovost-Morgan, Kyle T. Greenway, Leor Roseman et al. · Nature Medicine · 2025 · 23 citations · Full text

Medicine, Pharmacology, Psychiatry +13